Skip to main content
Erschienen in: BMC Pregnancy and Childbirth 1/2022

Open Access 01.12.2022 | Research

Risk factors for twin pregnancy in women undergoing double cleavage embryo transfer

verfasst von: Panpan Chen, Kai-Lun Hu, Jiani Jin, Ruixue Chen, Qiqi Xu, Wei Zhao, Runju Zhang, Lanfeng Xing, Yimin Zhu, Dan Zhang

Erschienen in: BMC Pregnancy and Childbirth | Ausgabe 1/2022

Abstract

Background

Two or more embryo transfers have been used to increase the success rate of live birth in traditional in vitro fertilization (IVF) strategy at the expense of increased risks of multiple pregnancy and adverse perinatal outcomes. The decision regarding the elective single embryo transfer or double embryo transfer remains inconclusive. The aim of this study was to investigate the risk factors for twin pregnancy in IVF.

Methods

Participants who underwent their first fresh IVF cycle where two cleavage stage embryos were transferred in Women’s Hospital of Zhejiang University between January 2010 and December 2018 were included in this retrospective cohort study. The primary outcome was twin delivery. Secondary outcomes included preterm birth and low birth weight

Results

Fifteen thousand four hundred fifty-nine women were available for final analysis, in which 1511 women resulted in twin delivery and 4788 women had singleton delivery. Female age over 35 was associated with reduced rates of twin pregnancy compared with female age at or less than 35 (9.5% vs 25.1%, aRR = 0.38 (0.27. 0.55)). Poor-type endometrium was associated with reduced rates of twin pregnancy (19.2% vs 27.5%, aRR = 0.75 (0.58. 0.96)). Two good-quality embryos for transfer was associated with significantly higher rates of twin pregnancy compared with one good-quality or none good-quality embryo (26% vs 12.8% vs 9.3%, aRR = 0.56 (0.45. 0.70), aRR = 0.44(0.26. 0.74)). Female age over 35 and none or one good-quality embryo for transfer were associated with reduced rate of low birth weight and preterm birth.

Conclusion

Women with age over 35, poor-type endometrium, one good-quality embryo or none good-quality embryo were associated with reduced rate for twin pregnancy.
Hinweise

Supplementary Information

The online version contains supplementary material available at https://​doi.​org/​10.​1186/​s12884-022-04606-1.
Panpan Chen, Kai-Lun Hu and Jiani Jin contributed equally to this work and share first authorship.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Background

In vitro fertilization (IVF) has allowed millions of infertile couples to get conception since the year 1978 [1]. IVF is more commonly used in recent years due to the increase of infertile couples [25]. However, IVF treatment is associated with the increased risk of several adverse obstetric and neonatal outcomes, including multiple pregnancy [6, 7], ovarian hyperstimulation syndrome (OHSS) [8], preterm birth [9, 10], low birthweight [11, 12], and small for gestational age [1315].
Two or more embryo transfers have been used to increase the success rate of live birth in traditional IVF strategy [16, 17]. However, the risk of multiple pregnancy is also increased following the transfer of multiple embryos [18]. Multiple pregnancy is associated with increased risks of premature birth, placental related diseases (preeclampsia, gestational hypertension, placental abruption), cesarean section, and postpartum bleeding [1924]. In addition, compared with singleton pregnancy, multiple pregnancy results in higher risks of several adverse neonatal outcomes, including low birth weight, fetal or neonatal death, and congenital malformations [25, 26]. Multiple pregnancy rate following IVF has been reduced over time due to the increased application of transfers with fewer and better-quality embryos [18, 2729]. More recently, elective single embryo transfer has been increasingly popular. However, the decision towards elective single embryo transfer or double embryo transfer remains inconclusive up to now [30, 31], which needs to be further explored.
Previous studies demonstrated that the factors associated with twin pregnancy in women undergoing IVF include the increased height of women (> 1.74 cm), the younger age of women, a higher quality of transferred embryos, a high number of retrieved oocytes (> 8) [3234]. However, due to the small sample size, the omission of some important covariables, and the heterogenous inclusion of participants, several potential risk factors for twin pregnancy may be neglected. Therefore, in this retrospective chort study, we aimed to explore the risk factors of twin pregnancy in women with double embryo transfer. We also investigated whether the risk factors of twin pregnancy were associated with the adverse outcomes, including preterm birth and low birth weight. We analyzed the data that include those with failed pregnancies after embryo transfer because we would like to highlight how these risk factors could be used as a tool for both pre-transfer and post-transfer counselling [35, 36]. This made our analyses more notable than previous studies which only looked at risk factors as a post-transfer counselling tool.

Methods

This retrospective cohort study was approved by the Ethics Committee of Women’s Hospital of Zhejiang University. A total of 15,800 women who underwent their first double embryo transfer (DET) cycle from January 2010 to December 2018 in Women’s Hospital, Zhejiang University School of Medicine were enrolled in this study. Women with the following cycles were excluded: preimplantation genetic test (PGT); donor cycles; cyeles transferred with one; cleavage embryo and one blastocyst; cycles transferred with double blastocyst. Women who resulted in pregnancy was excluded if they had a triple pregnancy, monozygotic twins, fetal reduction, or loss of follow up. Gonadotropin-releasing hormone (GnRH) agonist or GnRH antagonist protocol was used for ovarian stimulation. Recombinant follicle stimulation hormone (FSH) (Gonafen, Pricon) and/or human menopausal gonadotrophin (Livzon, China) was commenced on day 2 or day 3 of the cycle at a dose of 75–225 IU, and the doses were adjusted according to the ovarian response (follicle count under ultrasound and/or serum E2 levels). When at least two leading follicles reached a size of around 18 mm, ovulation was induced by the administration of recombinant human chorionic gonadotropin (5000–6500 IU, Livzon, China); then, the oocyte was retrieved 36 to 38 h later. Fertilization was conducted by either conventional IVF or by an intracytoplasmic sperm injection (ICSI). Two embryos at the cleavage stage were transferred. The primary outcome was twin pregnancy defined as two live births after 22 weeks of gestation. Secondary outcomes included preterm birth (before 37 completed weeks of gestational age) and low birth weight (birth weight lower than 2500 g). The poor-type endometrium was defined as a multilayered endometrium consisting of prominent outer and midline hyperechogenic lines and inner hypoechogenic regions [37]. Cleavage embryos were graded according to the Istanbul consensus with 1 to 4 grade [38]. Grade I-II embryos were considered as good quality embryos, while Grade III-IV were considered as Poor-quality embryos. Thin endometrium was defined as endometrial thickness lower than 7 mm. Endometrial thickness at 7–14 mm was considered as the moderate endometrium and higher than 14 mm was considered as the thick emdometrium. High education was defined as a master degree or PhD degree. The number of oocyte retrieved at 0–5, 6–15, and > 16 were considered as poor ovarian response, moderate response, and high response, respectively.
Comparison between groups was performed using the independent sample t-test, Chi-square test (χ2), and non-parametric test as appropriate. Coefplot was used to visualize the risk factors for twin pregnancy, preterm birth, and low birth weight. A log-binomial regression model was used to calcualte the crude risk ratio (95% confidence interval) and adjusted risk ratio (95% confidence interval) of covaribles for the outcomes. The covariates included in the regression model included: female age (≤ 35 and > 35); male age (≤ 35 and > 35); female over weight (BMI < 25 and ≥ 25); male over weight: (BMI < 25 and ≥ 25); tubal factor; ovulatory dysfunction; male factor; endometriosis; endometrium type; sperm deviation; embryo quality; ICSI; smoking; endometrial thickness; the number of oocytes retrieve; Primary infertility; GnRH agonist and GnRH antagonist; education. All statistical procedures were run in Stata 15.1 (StataCorp LLC, Texas, USA). A p-value below 0.05 was considered as the statistical significance.

Results

Characteristics of enrolled patients

A total of 15,800 women who underwent their first DET cycle in the Women’s Hospital of Zhejiang University were enrolled. In these women, 51 were excluded because of PGT, none was excluded for donor cycles, 22 women were excluded due to the transfer of one cleavage embryo and one blastocyst, and 71 women were excluded due to double blastocyst transfer, 63 women were excluded because of triple pregnancy, 22 women were excluded with monozygotic twins, 81 women were excluded because the occurrence of pregnancr reduction and 31 women were excluded for lose of follow-up. At last, 15459 women were available for final analysis, in which 1511 women resulted in twin delivery, 4788 women had singleton delivery and 9170 women resulted in fail cycles (Fig. 1).
In women who underwent fresh embryo transfer cycles, twin pregnancy were associated with a reduced female age and male age, a higher rate of lower BMI, a higher number of oocytes, a thicker endometrium, a reduced years of infertity, a higher level of progesterone, a higher rate of endometriosis, GnRH agonist use, two good-quality embryos for transfer, high education, and high ovarian response (P < 0.001, P < 0.01, P < 0.01, P < 0.01, P < 0.01, P < 0.001, P < 0.01, P < 0.01, P < 0.01, P < 0.01, P < 0.01, P < 0.01) (Table 1). No statistically significant difference was found in male BMI, menarche, primary infertility, the level of FSH, LH, Estradiol and total testosterone, tubal factor, ovulatory dysfunction, male factor, sperm donor, fertilization methods, smoking among women resulted in twin pregnancy, single pregnancy and no pregnancy (Table 1).
Table 1
Characteristics of women undergoing fresh cycle
variables
Twins
(n = 1511)
Singleton
(n = 4778)
No delivery
(n = 9170)
P valuea
Female age y
29.4 ± 3.2
30.2 ± 3.7
30.7 ± 4.3
< 0.001
  >35
41 (3%)
391 (8%)
1224 (13%)
 
  ≤35
1470 (97%)
4387 (92%)
7946 (87%)
 
Male age y
31.7 ± 4.3
32.1 ± 4.6
32.9 ± 5.3
< 0.001
  >35
244 (16%)
991 (21%)
2424 (26%)
 
  ≤35
1265 (84%)
3786 (79%)
6737 (74%)
 
Female BMI kg/m2
21.8 ± 2.7
21.9 ± 2.8
22.1 ± 2.9
< 0.001
  ≥25
191 (13%)
661 (13.8%)
1450 ± (16%)
0.24
  <25
1317 (87.3%)
4116 (86.2%)
7717 ± (84%)
 
Male BMI kg/m2
23.7 ± 3.7
23.7 ± 3.6
23.7 ± 3.6
0.88
  ≥25
487 (33%)
1573 (33%)
2936 (33%)
 
  <25
992 (67%)
3135 (67%)
6038 (67%)
 
Primary infertility
742 (49%)
2278 (48%)
4302 (47%)
0.25
FSH mIU/ml
7 (6–8)
7 (6–8)
7 (6–8)
0.44
LH mIU/ml
5 (3–6)
5 (3–6)
5 (3–6)
0.10
Estradiol pmol/l
113 (81–145)
111 (79–148)
114 (82–153)
0.008
Progesterone nmol/l
1.6 (1.1–2.3)
1.5 (1.1–2.1)
1.6 (1.1–2.2)
< 0.001
Total testosterone nmol/l
0.8 (0.5–1.1)
0.7 (0.5–1.1)
0.79 (0.5–1.1)
0.22
Reason for IVF
  Tubal factor
842 (56%)
2601 (54%)
4993 (54%)
0.64
  Ovulatory dysfunction
85 (5.6%)
316 (6.6%)
643 (7.0%)
0.12
  Male factor
447 (30%)
1586 (33%)
2960 (32%)
0.033
  Endometriosis
188 (12.4%)
571 (12.0%)
866 (9.4%)
< 0.001
  Down-regulation
   
< 0.001
  GnRH agonist
1310 (86.7%)
3671 (76.8%)
7185 (78.4%)
 
  GnRH antagonist
182 (12%)
1019 (21.3%)
1807 (19.7%)
 
  Other
19 (1.3%)
88 (1.8%)
178 (1.9%)
 
Sperm donor
27 (2.0%)
77 (2.1%)
108 (1.4%)
0.012
ICSI
392 (8.7%)
1392 (30.9%)
2723 (60.4%)
0.01
Poor-type endometrium
60 (4.8%)
253 (7.5%)
432 (6.0%)
0.001
Embryo quality
   
< 0.001
  GG
1360 (92.2%)
3864 (82.2%)
7010 (78.1%)
 
  GP
97 (6.6%)
663 (14.1%)
1257 (14.0%)
 
  PP
18 (1.2%)
175 (3.7%)
712 (7.9%)
 
  High education
703 (46.6%)
2276 (47.7%)
3792 (41.4%)
< 0.001
Smoking
   
0.275
  Yes
5 (0.3%)
27 (0.6%)
61 (0.7%)
 
  No
1505 (99.7%)
4747 (99.4%)
9102 (99.3%)
 
Endometrial thickness mm
11.3 ± 2.4
11.1 ± 2.4
10.7 ± 2.4
< 0.001
  Moderate
1288 (86%)
4068 (87%)
7938 (88%)
 
  Thin
18 (1%)
81 (2%)
271 (3%)
 
  Thick
184 (12%)
545 (12%)
824 (9%)
 
Total number of oocytes
11.4 ± 4.8
10.9 ± 4.9
10.8 ± 5.0
< 0.001
Ovarian response
   
< 0.001
  Moderate
1067 (71%)
3348 (70%)
6297 (69%)
 
  Poor
155 (10%)
639 (13%)
1349 (15%)
 
  High
289 (19%)
790 (17%)
1519 (17%)
 
χ2, non-parametric test, or t test as appropriate. Data expressed with Mean ± SD or Median (IQR) or Number (percent) as appropriate. GG, two good-quality embryo; GP, one good-quality embryo and one poor-quality embryo; PP, two poor-quality embryo
Notes: Poor-type endometrium: A multilayered endometrium consisting of prominent outer and midline hyperechogenic lines and inner hypoechogenic regions. Good quality embryos: Grade I-II embryos; Poor-quality embryos: Grade III-IV embryos. Thin endometrium: Endometrial thickness lower than 7 mm; Moderate endometrium: Endometrial thickness at 7–14 mm; Thick endometrium: Endometrial thickness higher than 14 mm. High education: A master degree or PhD degree. Poor ovarian response: 0–5 oocytes retrieved; Moderate ovarian response: 6–15 oocytes retrieved; High ovarian response: > 16 oocytes retrieved
Sex hormones (FSH, LH, Progesterone, and Total testosterone) were measured on day 2–5 of menstrual cycle
In women who underwent fresh embryo transfer cycle, female age over 35 was associated with reduced rates of twin pregnancy compared with female age at or less than 35 (2% vs 11%, aRR = 0.38 (0.27. 0.55)). Women whose partner age was over 35 showed reduced rates of twin pregnancy compared with women whose partner age was at or less than 35 (7% vs 11%, aRR = 0.82 (0.70. 0.96)). Female who had two good-quality embryos was associated with higher rates of twin pregnancy compared with female who had one good-quality or none good-quality embryo (11.1% vs 4.8% vs 2.0%, aRR = 0.48 (0.38. 0.61), aRR = 0.21(0.12. 0.36)). Female with thin endometrium were associated with reduced rates of twin pregnancy (4.9%, aRR = 0.46 (0.26. 0.82)). Women with thick showed higher rates of twin pregnancy (11.8%, aRR = 1.21 (1.03, 1.43)). Women with GnRH agonist and high education were associated with a higher rate of twin pregnancy (10.8%, aRR = 1.22 (1.01, 1.46), 10.4%, aRR = 1.23 (1.09, 1.38). Female overweight, male overweight, the reasons for IVF including tuabal factor, ovaulatory dysfunction, male factor and endometriosis, endometrium type, sperm donor, fertilization method, smoking, poor or high ovarian response and primary infertility were not associated with twin pregnancy rates (Fig. 2).
In women who resulted in pregnancies, female age over 35 was associated with reduced rates of twin pregnancy compared with female age at or less than 35 (9.5% vs 25.1%, aRR = 0.38 (0.27. 0.55)). Women with poor-type endometrium was associated with reduced rates of twin pregnancy (19.2% vs 27.5%, aRR = 0.75 (0.58. 0.96)). Female who had two good-quality embryos for transfer showed significantly higher rates of twin pregnancy compared with female who had one good-quality or none good-quality embryo (26% vs 12.8% vs 9.3%, aRR = 0.56 (0.45. 0.70), aRR = 0.44(0.26. 0.74)). We found no significance in female and male overweight, the reasons for IVF (tubal factor, ovulatory dysfunction, male factor, endometriosis), poor-type endometrium, fertilization methods, smoking, with the proportion of thin or thick endometrium, ovarian response, primary infertility, GnRH agonist, and high education (Fig. 2).
Women with age over 35 and women with none or one good-quality embryo for transfer were associated with reduced rate of low birth weight (per transfer cycle and per pregnancy, Supplemental Figure 1). However, women with poor-type endometrium, high education, and thick endometrium were associated with increased rate of fetal low birth weight (per transfer cycle, Supplemental Figure 1).
Women with age over 35 and women with none or one good-quality embryo for transfer were associated with reduced rates of preterm birth (per transfer cycle and per pregnancy, Supplemental Figure 2). In women underwent per transfer cycle, women with high education and women with thick endometrium were associated with increased rate of pretern birth (per transfer cycle Supplemental Figure 2).

Discussion

In this study, we showed that women with age over 35, one good-quality embryo and none good-quality embryo were associated with reduced rate for twin pregnancy (per cycle and per pregnancy). There was a trend towards an increased rate of twin pregnancy in women with high education and women with GnRH agonist.
Previous studies demonstrated that the good-quality embryos and a high number of retrieved oocytes increase the chance of dizygotic twinning after IVF with DET [32, 3942]. Consistent with previous studies, our data demonstrated that women transferred with two good-quality embryos showed higher rates of twin pregnancy compared with women transferred with one or none good-quality embryo. However, our study demonstrated that women with high ovarian response were not associated with increased rates of twin pregnancy. Due to the inadvanced embryo frozen technology in the past decade, the strategy of transferring multiple embryos is often preferred, which leads to increased rates of twin pregnancy. Our research included women who underwent fresh embryo transfer, and if the number of oocytes retrieved was greater than 20, we generally chose to freeze all embryos instead of fresh transfer. Table 1 showed that the proportion of women with high ovarian response is relatively low and the average number of oocytes is around 11. On the other hand, previous studies have often decided to transfer two or more embryos in women with a large number of oocytes, which leads to an increase rate of twin pregnancy [42, 43]. These data may explain the difference between our study and previous studies regarding to the association of high response with twin pregnancy rate. Furthermore, our data also demonstrated that women with good-type endometrium and age under 35 were associated with a higher rate of twin pregnancy, which have not been determined in previous studies. Therefore, these women need to be cautious when choosing double embryo transfer because the rates of twin pregnancy tend to increase in these women.
At the same time, we also explored the risk factors of premature birth and low birth weight infants. Our datas showed that women with age under 35 and women transferred with two good-quality embryos were associated with a higher rate of twin pregnancy as well as preterm birth and low birth weight. In addition, previous studies have shown that twin pregnancy may lead to premature birth and low birth weight infants [44, 45]. Overall, these data strongly suggested the adverse outcomes in women with age under 35 and women transferred with two good-quality embryos. Thus, an elective single embryo transfer should be considered in women with age under 35 and with good-quality embryos. Additionally, there is a trend towards an increased risk of twin pregnancy, perterm birth, and low birth weight in women with high education and women with GnRH agonist use. One study explored the association between educational attainment and twin pregnancies, and the study found no significant association [32]. Our study found there is a trend towards an increased risk of twin pregnancy in women with high education, the result could be random and should be further confirmed by future studies with large sample size. An elective single embryo transfer should also be preferred in these women.
Our study has several limitaions. Duo to the retrospective nature, some potential factors that may be associated with the studied outcomes were not included. Additionally, the obstetric outcomes were not available to analyse in our dataset.

Conclusions

In the present study, we showed that women with age over 35, one good-quality embryo and none good-quality embryo were associated with reduced rate of twin pregnancy (per cycle and per pregnancy). There is a trend towards an increased rate of twin pregnancy in women with high education and women with GnRH agonist.

Acknowledgements

We want to thank Saijuan Sun at Women’s Hospital, Zhejiang University School of Medicine for helping with the electronic database.

Declarations

This study was approved by the Ethics Committee of Women’s Hospital of Zhejiang University. All the study procedures were carried out in accordance with relevant guidelines. Written informed consent was obtained from all the participants involved in the study.
Not applicable.

Competing interests

The authors declare that they have no competing interests.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Anhänge
Literatur
1.
Zurück zum Zitat Steptoe PC, Edwards RG. Birth after the reimplantation of a human embryo. Lancet. 1978;2(8085):366.PubMedCrossRef Steptoe PC, Edwards RG. Birth after the reimplantation of a human embryo. Lancet. 1978;2(8085):366.PubMedCrossRef
3.
Zurück zum Zitat Ragni G, Mosconi P, Baldini MP, Somigliana E, Vegetti W, Caliari I, et al. Health-related quality of life and need for IVF in 1000 Italian infertile couples. Hum Reprod. 2005;20(5):1286–91.PubMedCrossRef Ragni G, Mosconi P, Baldini MP, Somigliana E, Vegetti W, Caliari I, et al. Health-related quality of life and need for IVF in 1000 Italian infertile couples. Hum Reprod. 2005;20(5):1286–91.PubMedCrossRef
4.
Zurück zum Zitat Boivin J, Bunting L, Collins JA, Nygren KG. International estimates of infertility prevalence and treatment-seeking: potential need and demand for infertility medical care. Hum Reprod. 2007;22(6):1506–12.PubMedCrossRef Boivin J, Bunting L, Collins JA, Nygren KG. International estimates of infertility prevalence and treatment-seeking: potential need and demand for infertility medical care. Hum Reprod. 2007;22(6):1506–12.PubMedCrossRef
5.
Zurück zum Zitat Kupka MS, Ferraretti AP, de Mouzon J, Erb K, D'Hooghe T, Castilla JA, et al. Assisted reproductive technology in Europe, 2010: results generated from European registers by ESHRE†. Hum Reprod. 2014;29(10):2099–113.PubMedCrossRef Kupka MS, Ferraretti AP, de Mouzon J, Erb K, D'Hooghe T, Castilla JA, et al. Assisted reproductive technology in Europe, 2010: results generated from European registers by ESHRE†. Hum Reprod. 2014;29(10):2099–113.PubMedCrossRef
6.
7.
Zurück zum Zitat Kerin JF, Warnes GM, Quinn PJ, Jeffrey R, Kirby C, Matthews CD, et al. Incidence of multiple pregnancy after in-vitro fertilisation and embryo transfer. Lancet. 1983;2(8349):537–40.PubMedCrossRef Kerin JF, Warnes GM, Quinn PJ, Jeffrey R, Kirby C, Matthews CD, et al. Incidence of multiple pregnancy after in-vitro fertilisation and embryo transfer. Lancet. 1983;2(8349):537–40.PubMedCrossRef
8.
Zurück zum Zitat Macklon NS, Stouffer RL, Giudice LC, Fauser BC. The science behind 25 years of ovarian stimulation for in vitro fertilization. Endocr Rev. 2006;27(2):170–207.PubMedCrossRef Macklon NS, Stouffer RL, Giudice LC, Fauser BC. The science behind 25 years of ovarian stimulation for in vitro fertilization. Endocr Rev. 2006;27(2):170–207.PubMedCrossRef
9.
Zurück zum Zitat Tan SL, Doyle P, Campbell S, Beral V, Rizk B, Brinsden P, et al. Obstetric outcome of in vitro fertilization pregnancies compared with normally conceived pregnancies. Am J Obstet Gynecol. 1992;167(3):778–84.PubMedCrossRef Tan SL, Doyle P, Campbell S, Beral V, Rizk B, Brinsden P, et al. Obstetric outcome of in vitro fertilization pregnancies compared with normally conceived pregnancies. Am J Obstet Gynecol. 1992;167(3):778–84.PubMedCrossRef
10.
Zurück zum Zitat Friedler S, Mashiach S, Laufer N. Births in Israel resulting from in-vitro fertilization/embryo transfer, 1982-1989: National Registry of the Israeli Association for Fertility Research. Hum Reprod. 1992;7(8):1159–63.PubMedCrossRef Friedler S, Mashiach S, Laufer N. Births in Israel resulting from in-vitro fertilization/embryo transfer, 1982-1989: National Registry of the Israeli Association for Fertility Research. Hum Reprod. 1992;7(8):1159–63.PubMedCrossRef
11.
Zurück zum Zitat Balen AH, MacDougall J, Tan SL. The influence of the number of embryos transferred in 1060 in-vitro fertilization pregnancies on miscarriage rates and pregnancy outcome. Hum Reprod. 1993;8(8):1324–8.PubMedCrossRef Balen AH, MacDougall J, Tan SL. The influence of the number of embryos transferred in 1060 in-vitro fertilization pregnancies on miscarriage rates and pregnancy outcome. Hum Reprod. 1993;8(8):1324–8.PubMedCrossRef
12.
Zurück zum Zitat Gissler M, Malin Silverio M, Hemminki E. In-vitro fertilization pregnancies and perinatal health in Finland 1991-1993. Hum Reprod. 1995;10(7):1856–61.PubMedCrossRef Gissler M, Malin Silverio M, Hemminki E. In-vitro fertilization pregnancies and perinatal health in Finland 1991-1993. Hum Reprod. 1995;10(7):1856–61.PubMedCrossRef
13.
Zurück zum Zitat Bergh T, Ericson A, Hillensjö T, Nygren KG, Wennerholm UB. Deliveries and children born after in-vitro fertilisation in Sweden 1982-95: a retrospective cohort study. Lancet. 1999;354(9190):1579–85.PubMedCrossRef Bergh T, Ericson A, Hillensjö T, Nygren KG, Wennerholm UB. Deliveries and children born after in-vitro fertilisation in Sweden 1982-95: a retrospective cohort study. Lancet. 1999;354(9190):1579–85.PubMedCrossRef
14.
Zurück zum Zitat Klemetti R, Gissler M, Hemminki E. Comparison of perinatal health of children born from IVF in Finland in the early and late 1990s. Hum Reprod. 2002;17(8):2192–8.PubMedCrossRef Klemetti R, Gissler M, Hemminki E. Comparison of perinatal health of children born from IVF in Finland in the early and late 1990s. Hum Reprod. 2002;17(8):2192–8.PubMedCrossRef
15.
Zurück zum Zitat Koivurova S, Hartikainen AL, Gissler M, Hemminki E, Sovio U, Järvelin MR. Neonatal outcome and congenital malformations in children born after in-vitro fertilization. Hum Reprod. 2002;17(5):1391–8.PubMedCrossRef Koivurova S, Hartikainen AL, Gissler M, Hemminki E, Sovio U, Järvelin MR. Neonatal outcome and congenital malformations in children born after in-vitro fertilization. Hum Reprod. 2002;17(5):1391–8.PubMedCrossRef
16.
Zurück zum Zitat Gelbaya TA, Tsoumpou I, Nardo LG. The likelihood of live birth and multiple birth after single versus double embryo transfer at the cleavage stage: a systematic review and meta-analysis. Fertil Steril. 2010;94(3):936–45.PubMedCrossRef Gelbaya TA, Tsoumpou I, Nardo LG. The likelihood of live birth and multiple birth after single versus double embryo transfer at the cleavage stage: a systematic review and meta-analysis. Fertil Steril. 2010;94(3):936–45.PubMedCrossRef
17.
Zurück zum Zitat Pandian Z, Templeton A, Serour G, Bhattacharya S. Number of embryos for transfer after IVF and ICSI: a Cochrane review. Hum Reprod. 2005;20(10):2681–7.PubMedCrossRef Pandian Z, Templeton A, Serour G, Bhattacharya S. Number of embryos for transfer after IVF and ICSI: a Cochrane review. Hum Reprod. 2005;20(10):2681–7.PubMedCrossRef
18.
Zurück zum Zitat Luke B. Pregnancy and birth outcomes in couples with infertility with and without assisted reproductive technology: with an emphasis on US population-based studies. Am J Obstet Gynecol. 2017;217(3):270–81.PubMedCrossRef Luke B. Pregnancy and birth outcomes in couples with infertility with and without assisted reproductive technology: with an emphasis on US population-based studies. Am J Obstet Gynecol. 2017;217(3):270–81.PubMedCrossRef
19.
Zurück zum Zitat Sebire NJ, Jolly M, Harris J, Nicolaides KH, Regan L. Risks of obstetric complications in multiple pregnancies: an analysis of more than 400 000 pregnancies in the UK. Prenatal Neonatal Med. 2001;6(2):89–94. Sebire NJ, Jolly M, Harris J, Nicolaides KH, Regan L. Risks of obstetric complications in multiple pregnancies: an analysis of more than 400 000 pregnancies in the UK. Prenatal Neonatal Med. 2001;6(2):89–94.
20.
Zurück zum Zitat Martin JA, Hamilton BE, Ventura SJ, Menacker F, Park MM, Sutton PD. Births: final data for 2001. Natl Vital Stat Rep. 2002;51(2):1–102.PubMed Martin JA, Hamilton BE, Ventura SJ, Menacker F, Park MM, Sutton PD. Births: final data for 2001. Natl Vital Stat Rep. 2002;51(2):1–102.PubMed
21.
Zurück zum Zitat Narang K, Szymanski LM. Multiple gestations and hypertensive disorders of pregnancy: what do we know? Curr Hypertens Rep. 2020;23(1):1.PubMedCrossRef Narang K, Szymanski LM. Multiple gestations and hypertensive disorders of pregnancy: what do we know? Curr Hypertens Rep. 2020;23(1):1.PubMedCrossRef
22.
Zurück zum Zitat Aviram A, Berger H, Abdulaziz KE, Barrett JFR, Murray-Davis B, McDonald SD, et al. Outcomes associated with hypertensive disorders of pregnancy in twin compared with singleton gestations. Obstet Gynecol. 2021;138(3):449–58.PubMedCrossRef Aviram A, Berger H, Abdulaziz KE, Barrett JFR, Murray-Davis B, McDonald SD, et al. Outcomes associated with hypertensive disorders of pregnancy in twin compared with singleton gestations. Obstet Gynecol. 2021;138(3):449–58.PubMedCrossRef
23.
Zurück zum Zitat Hubinont C, Lewi L, Bernard P, Marbaix E, Debiève F, Jauniaux E. Anomalies of the placenta and umbilical cord in twin gestations. Am J Obstet Gynecol. 2015;213(4 Suppl):S91–s102.PubMedCrossRef Hubinont C, Lewi L, Bernard P, Marbaix E, Debiève F, Jauniaux E. Anomalies of the placenta and umbilical cord in twin gestations. Am J Obstet Gynecol. 2015;213(4 Suppl):S91–s102.PubMedCrossRef
24.
Zurück zum Zitat Henry DE, McElrath TF, Smith NA. Preterm severe preeclampsia in singleton and twin pregnancies. J Perinatol. 2013;33(2):94–7.PubMedCrossRef Henry DE, McElrath TF, Smith NA. Preterm severe preeclampsia in singleton and twin pregnancies. J Perinatol. 2013;33(2):94–7.PubMedCrossRef
25.
Zurück zum Zitat Scher AI, Petterson B, Blair E, Ellenberg JH, Grether JK, Haan E, et al. The risk of mortality or cerebral palsy in twins: a collaborative population-based study. Pediatr Res. 2002;52(5):671–81.PubMedCrossRef Scher AI, Petterson B, Blair E, Ellenberg JH, Grether JK, Haan E, et al. The risk of mortality or cerebral palsy in twins: a collaborative population-based study. Pediatr Res. 2002;52(5):671–81.PubMedCrossRef
26.
Zurück zum Zitat Ericson A, Källén B. Congenital malformations in infants born after IVF: a population-based study. Hum Reprod. 2001;16(3):504–9.PubMedCrossRef Ericson A, Källén B. Congenital malformations in infants born after IVF: a population-based study. Hum Reprod. 2001;16(3):504–9.PubMedCrossRef
27.
Zurück zum Zitat Maheshwari A, Griffiths S, Bhattacharya S. Global variations in the uptake of single embryo transfer. Hum Reprod Update. 2011;17(1):107–20.PubMedCrossRef Maheshwari A, Griffiths S, Bhattacharya S. Global variations in the uptake of single embryo transfer. Hum Reprod Update. 2011;17(1):107–20.PubMedCrossRef
28.
Zurück zum Zitat Tiitinen A, Unkila-Kallio L, Halttunen M, Hyden-Granskog C. Impact of elective single embryo transfer on the twin pregnancy rate. Hum Reprod. 2003;18(7):1449–53.PubMedCrossRef Tiitinen A, Unkila-Kallio L, Halttunen M, Hyden-Granskog C. Impact of elective single embryo transfer on the twin pregnancy rate. Hum Reprod. 2003;18(7):1449–53.PubMedCrossRef
29.
Zurück zum Zitat Milne P, Cottell E, Allen C, Spillane H, Vasallo J, Wingfield M. Reducing twin pregnancy rates after IVF--elective single embryo transfer (eSET). Ir Med J. 2010;103(1):9–11.PubMed Milne P, Cottell E, Allen C, Spillane H, Vasallo J, Wingfield M. Reducing twin pregnancy rates after IVF--elective single embryo transfer (eSET). Ir Med J. 2010;103(1):9–11.PubMed
30.
Zurück zum Zitat Ma S, Peng Y, Hu L, Wang X, Xiong Y, Tang Y, et al. Comparisons of benefits and risks of single embryo transfer versus double embryo transfer: a systematic review and meta-analysis. Reprod Biol Endocrinol. 2022;20(1):20.PubMedPubMedCentralCrossRef Ma S, Peng Y, Hu L, Wang X, Xiong Y, Tang Y, et al. Comparisons of benefits and risks of single embryo transfer versus double embryo transfer: a systematic review and meta-analysis. Reprod Biol Endocrinol. 2022;20(1):20.PubMedPubMedCentralCrossRef
31.
Zurück zum Zitat Kamath MS, Mascarenhas M, Kirubakaran R, Bhattacharya S. Number of embryos for transfer following in vitro fertilisation or intra-cytoplasmic sperm injection. Cochrane Database Syst Rev 2020;8(8):Cd003416. Kamath MS, Mascarenhas M, Kirubakaran R, Bhattacharya S. Number of embryos for transfer following in vitro fertilisation or intra-cytoplasmic sperm injection. Cochrane Database Syst Rev 2020;8(8):Cd003416.
32.
Zurück zum Zitat Groeneveld E, Lambers MJ, Stakelbeek ME, Mooij TM, van den Belt-Dusebout AW, Heymans MW, et al. Factors associated with dizygotic twinning after IVF treatment with double embryo transfer. Hum Reprod. 2012;27(10):2966–70.PubMedCrossRef Groeneveld E, Lambers MJ, Stakelbeek ME, Mooij TM, van den Belt-Dusebout AW, Heymans MW, et al. Factors associated with dizygotic twinning after IVF treatment with double embryo transfer. Hum Reprod. 2012;27(10):2966–70.PubMedCrossRef
33.
Zurück zum Zitat Hunault CC, Eijkemans MJ, Pieters MH, te Velde ER, Habbema JD, Fauser BC, et al. A prediction model for selecting patients undergoing in vitro fertilization for elective single embryo transfer. Fertil Steril. 2002;77(4):725–32.PubMedCrossRef Hunault CC, Eijkemans MJ, Pieters MH, te Velde ER, Habbema JD, Fauser BC, et al. A prediction model for selecting patients undergoing in vitro fertilization for elective single embryo transfer. Fertil Steril. 2002;77(4):725–32.PubMedCrossRef
34.
Zurück zum Zitat Vilska S, Tiitinen A, Hydén-Granskog C, Hovatta O. Elective transfer of one embryo results in an acceptable pregnancy rate and eliminates the risk of multiple birth. Hum Reprod. 1999;14(9):2392–5.PubMedCrossRef Vilska S, Tiitinen A, Hydén-Granskog C, Hovatta O. Elective transfer of one embryo results in an acceptable pregnancy rate and eliminates the risk of multiple birth. Hum Reprod. 1999;14(9):2392–5.PubMedCrossRef
35.
Zurück zum Zitat Hu KL, Kawai A, Hunt S, Li W, Li X, Zhang R, et al. Endometrial thickness in the prediction of neonatal adverse outcomes in frozen cycles for singleton pregnancies. Reprod BioMed Online. 2021;43(3):553–60.PubMedCrossRef Hu KL, Kawai A, Hunt S, Li W, Li X, Zhang R, et al. Endometrial thickness in the prediction of neonatal adverse outcomes in frozen cycles for singleton pregnancies. Reprod BioMed Online. 2021;43(3):553–60.PubMedCrossRef
36.
Zurück zum Zitat Liew Z, Olsen J, Cui X, Ritz B, Arah OA. Bias from conditioning on live birth in pregnancy cohorts: an illustration based on neurodevelopment in children after prenatal exposure to organic pollutants. Int J Epidemiol. 2015;44(1):345–54.PubMedPubMedCentralCrossRef Liew Z, Olsen J, Cui X, Ritz B, Arah OA. Bias from conditioning on live birth in pregnancy cohorts: an illustration based on neurodevelopment in children after prenatal exposure to organic pollutants. Int J Epidemiol. 2015;44(1):345–54.PubMedPubMedCentralCrossRef
37.
Zurück zum Zitat Gonen Y, Casper RF. Prediction of implantation by the sonographic appearance of the endometrium during controlled ovarian stimulation for in vitro fertilization (IVF). J In Vitro Fert Embryo Transf. 1990;7(3):146–52.PubMedCrossRef Gonen Y, Casper RF. Prediction of implantation by the sonographic appearance of the endometrium during controlled ovarian stimulation for in vitro fertilization (IVF). J In Vitro Fert Embryo Transf. 1990;7(3):146–52.PubMedCrossRef
38.
Zurück zum Zitat The Istanbul consensus workshop on embryo assessment. Proceedings of an expert meeting. Hum Reprod. 2011;26(6):1270–83.CrossRef The Istanbul consensus workshop on embryo assessment. Proceedings of an expert meeting. Hum Reprod. 2011;26(6):1270–83.CrossRef
39.
Zurück zum Zitat Basso O, Nohr EA, Christensen K, Olsen J. Risk of twinning as a function of maternal height and body mass index. Jama. 2004;291(13):1564–6.PubMedCrossRef Basso O, Nohr EA, Christensen K, Olsen J. Risk of twinning as a function of maternal height and body mass index. Jama. 2004;291(13):1564–6.PubMedCrossRef
40.
Zurück zum Zitat Basso O, Nohr EA, Olsen J, Christensen K. Relationship of maternal body mass index and height to twinning. Obstet Gynecol. 2005;106(2):411.PubMedCrossRef Basso O, Nohr EA, Olsen J, Christensen K. Relationship of maternal body mass index and height to twinning. Obstet Gynecol. 2005;106(2):411.PubMedCrossRef
41.
Zurück zum Zitat Hoekstra C, Willemsen G, van Beijsterveldt CE, Lambalk CB, Montgomery GW, Boomsma DI. Body composition, smoking, and spontaneous dizygotic twinning. Fertil Steril. 2010;93(3):885–93.PubMedCrossRef Hoekstra C, Willemsen G, van Beijsterveldt CE, Lambalk CB, Montgomery GW, Boomsma DI. Body composition, smoking, and spontaneous dizygotic twinning. Fertil Steril. 2010;93(3):885–93.PubMedCrossRef
42.
Zurück zum Zitat Min JK, Claman P, Hughes E. Guidelines for the number of embryos to transfer following in vitro fertilization No. 182, September 2006. Int J Gynaecol Obstet. 2008;102(2):203–16. Min JK, Claman P, Hughes E. Guidelines for the number of embryos to transfer following in vitro fertilization No. 182, September 2006. Int J Gynaecol Obstet. 2008;102(2):203–16.
43.
Zurück zum Zitat Cai Q, Wan F, Huang K, Zhang H. Does the number of oocytes retrieved influence pregnancy after fresh embryo transfer? PLoS One. 2013;8(2):e56189.PubMedPubMedCentralCrossRef Cai Q, Wan F, Huang K, Zhang H. Does the number of oocytes retrieved influence pregnancy after fresh embryo transfer? PLoS One. 2013;8(2):e56189.PubMedPubMedCentralCrossRef
44.
Zurück zum Zitat Eaton JL, Zhang X, Kazer RR. First-trimester bleeding and twin pregnancy outcomes after in vitro fertilization. Fertil Steril. 2016;106(1):140–3.PubMedCrossRef Eaton JL, Zhang X, Kazer RR. First-trimester bleeding and twin pregnancy outcomes after in vitro fertilization. Fertil Steril. 2016;106(1):140–3.PubMedCrossRef
45.
Zurück zum Zitat Bodnar LM, Himes KP, Abrams B, Lash TL, Parisi SM, Eckhardt CL, et al. Gestational weight gain and adverse birth outcomes in twin pregnancies. Obstet Gynecol. 2019;134(5):1075–86.PubMedPubMedCentralCrossRef Bodnar LM, Himes KP, Abrams B, Lash TL, Parisi SM, Eckhardt CL, et al. Gestational weight gain and adverse birth outcomes in twin pregnancies. Obstet Gynecol. 2019;134(5):1075–86.PubMedPubMedCentralCrossRef
Metadaten
Titel
Risk factors for twin pregnancy in women undergoing double cleavage embryo transfer
verfasst von
Panpan Chen
Kai-Lun Hu
Jiani Jin
Ruixue Chen
Qiqi Xu
Wei Zhao
Runju Zhang
Lanfeng Xing
Yimin Zhu
Dan Zhang
Publikationsdatum
01.12.2022
Verlag
BioMed Central
Erschienen in
BMC Pregnancy and Childbirth / Ausgabe 1/2022
Elektronische ISSN: 1471-2393
DOI
https://doi.org/10.1186/s12884-022-04606-1

Weitere Artikel der Ausgabe 1/2022

BMC Pregnancy and Childbirth 1/2022 Zur Ausgabe

Antikörper-Wirkstoff-Konjugat hält solide Tumoren in Schach

16.05.2024 Zielgerichtete Therapie Nachrichten

Trastuzumab deruxtecan scheint auch jenseits von Lungenkrebs gut gegen solide Tumoren mit HER2-Mutationen zu wirken. Dafür sprechen die Daten einer offenen Pan-Tumor-Studie.

Mammakarzinom: Senken Statine das krebsbedingte Sterberisiko?

15.05.2024 Mammakarzinom Nachrichten

Frauen mit lokalem oder metastasiertem Brustkrebs, die Statine einnehmen, haben eine niedrigere krebsspezifische Mortalität als Patientinnen, die dies nicht tun, legen neue Daten aus den USA nahe.

S3-Leitlinie zur unkomplizierten Zystitis: Auf Antibiotika verzichten?

15.05.2024 Harnwegsinfektionen Nachrichten

Welche Antibiotika darf man bei unkomplizierter Zystitis verwenden und wovon sollte man die Finger lassen? Welche pflanzlichen Präparate können helfen? Was taugt der zugelassene Impfstoff? Antworten vom Koordinator der frisch überarbeiteten S3-Leitlinie, Prof. Florian Wagenlehner.

Gestationsdiabetes: In der zweiten Schwangerschaft folgenreicher als in der ersten

13.05.2024 Gestationsdiabetes Nachrichten

Das Risiko, nach einem Gestationsdiabetes einen Typ-2-Diabetes zu entwickeln, hängt nicht nur von der Zahl, sondern auch von der Reihenfolge der betroffenen Schwangerschaften ab.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.